Discontinuation due to immune‐related adverse events is a...

  • Main
  • 2019 / 07
  • Discontinuation due to immune‐related adverse events is a...

Discontinuation due to immune‐related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non‐small cell lung cancer

Komiya, Kazutoshi, Nakamura, Tomomi, Abe, Tomonori, Ogusu, Shinsuke, Nakashima, Chiho, Takahashi, Koichiro, Kimura, Shinya, Sueoka‐Aragane, Naoko
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Thoracic Cancer
DOI:
10.1111/1759-7714.13149
Date:
July, 2019
File:
PDF, 287 KB
2019
Conversion to is in progress
Conversion to is failed